Litcius/Paper detail

Validation of Clinical Risk Models for Clostridioides difficile<i>-</i>Attributable Outcomes

Gregory R. Madden, William A. Petri, Deiziane Viana da Silva Costa, Cirle A. Warren, Z. Jennie, Costi D. Sifri

2022Antimicrobial Agents and Chemotherapy13 citationsDOIOpen Access PDF

Abstract

Clostridioides difficile is the leading health care-associated pathogen, leading to substantial morbidity and mortality; however, there is no widely accepted model to predict C. difficile infection severity. Most currently available models perform poorly or were calibrated to predict outcomes that are not clinically relevant.

Topics & Concepts

MedicineReceiver operating characteristicInternal medicineConfidence intervalRetrospective cohort studyClostridioidesClostridium difficileEmergency medicineAntibioticsMicrobiologyBiologyClostridium difficile and Clostridium perfringens researchMicroscopic ColitisHelicobacter pylori-related gastroenterology studies
Validation of Clinical Risk Models for Clostridioides difficile<i>-</i>Attributable Outcomes | Litcius